Keyphrases
Accelerated Aging
47%
Acute Kidney Injury
23%
Aging
23%
Anticancer Therapy
23%
Biodistribution
23%
Biological Fate
23%
Caloric Intake
19%
Caloric Restriction
74%
Calories
47%
Cancer Patients
23%
Cancer Treatment
23%
Chemotherapy
47%
Chemotherapy Side Effects
47%
Clearance Mechanism
23%
Degree of Exposure
23%
Detoxification Mechanism
23%
Differentiation Status
23%
DNA Damage
47%
DNA Lesions
23%
DNA Metabolism
23%
DNA Replication
23%
Exposure Outcome
23%
Improved Survival
23%
Intermittent Fasting
100%
Life-sustaining Treatment
23%
Living Kidney Donor
47%
Ment
23%
Metabolic State
23%
Microenvironment
23%
Multicenter Randomized Controlled Trial
47%
Negative Side Effects
23%
Nutritional Intervention
47%
Organ System
23%
Patient Demographics
23%
Pediatric
23%
Pediatric Cancer
23%
Postoperative Fatigue
33%
Postoperative Recovery
47%
Quality of Life
30%
Recent Advances
23%
Recovery Studies
47%
Reduced Toxicity
47%
Renal Tumor
47%
Resilience Mechanisms
19%
RNA Transcription
23%
State Activity
23%
Survival Rate
23%
Systematic Scoping Review
47%
Therapeutic Agents
23%
Well-being
47%
Medicine and Dentistry
Accelerated Aging
31%
Acute Kidney Injury
35%
Acute Stress
11%
Anti-Inflammatory Drug
11%
Antiinfective Agent
15%
Biodistribution
15%
Caloric Intake
23%
Caloric Restriction
94%
Cancer Treatment
31%
Cell Cycle
15%
Cell Differentiation
15%
Chemotherapy
47%
Childhood Cancer
11%
Chronic Kidney Disease
11%
Cytokine Production
11%
Cytoprotective Agent
11%
Detoxication
15%
Diet Therapy
11%
DNA Damage
47%
DNA Metabolism
15%
DNA RNA Hybridization
15%
DNA Synthesis
15%
Five-Year Survival Rate
11%
Immunomodulation
11%
Inflammatory Cytokine
11%
Intervention Study
11%
Kidney Function
35%
Kidney Surgery
11%
Kidney Tumour
47%
Laxative
11%
Low Drug Dose
11%
Malignant Neoplasm
59%
Metabolism
15%
Microenvironment
15%
Nutritional Intervention
47%
Organ Systems
15%
Patient Population
23%
Pediatric Cancer
15%
Pediatrics
15%
Physical Stress
11%
Physical Well-Being
11%
Postoperative Recovery
47%
Preoperative Fasting
23%
Quality of Life
27%
Randomized Clinical Trial
11%
Randomized Controlled Trial
47%
RNA Transcription
15%
Side Effect
71%
Survival Rate
15%
Wilms' Tumor
23%
